Condition (MeSH)
Penile Induration
ClinicalTrials.gov lists 46 trials for Penile Induration or a narrower condition beneath it. Endo USA Inc., a Keenova Therapeutics Company has the most among industry and government lead sponsors, with 9.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
46 of the 46 trials are tagged with Penile Induration itself; the rest are tagged with a narrower condition beneath it.
When did Penile Induration trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 5 |
| 2024 | 4 |
| 2023 | 7 |
| 2022 | 2 |
| 2021 | 6 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 3 |
| 2017 | 2 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 35 months from start to primary completion across 8 trials still running at the 2026-10-09 snapshot; registered median of 17 months across 26 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Penile Induration trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 4 |
| Phase 3 | 5 |
| Phase 4 | 6 |
| Not applicable | 18 |
| Observational | 7 |
How many Penile Induration trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Completed | 25 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Penile Induration trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Endo USA Inc., a Keenova Therapeutics Company | 9 |
| Hybrid Medical | 1 |
| IBSA Farmaceutici Italia Srl | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Clostridium Histolyticum Collagenase | 13 |
| [PRP] platelet rich plasma | 3 |
| Adipose tissue stem cell injection | 1 |
| NaCl 0.9% NS | 1 |
| AlloRx | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Penile Induration trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Prostate cancer | 6 | 3 |
| Fracture of penis | 4 | 3 |
| Pulmonary embolism | 4 | 2 |
| Arthritis | 3 | 3 |
| Atrial fibrillation | 3 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Penile Induration? (47)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Low-Intensity Extracorporeal Shock Wave Therapy and Platelet-Rich Plasma: Effective Combination Treatment of Chronic-Phase Peyronie's Disease. | Archivos espanoles de urologia | 2025 | Yes |
| A contemporary assessment of the evaluation and management of patients presenting to a tertiary medical center with Peyronie's disease. | International journal of impotence research | 2024 | Yes |
| Validation of the Italian version of the Peyronie's Disease Questionnaire (PDQ). | International journal of impotence research | 2024 | Yes |
| Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie's Disease. | Urology | 2024 | Yes |
| Surgical management of complex curvature in Peyronie's disease. | World journal of urology | 2024 | Yes |
Showing 5 of 47 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.